Objective: To study the clinical and bacteriological features of Campy
lobacter infections in HIV-infected patients. Design: A retrospective
analysis (1989-1992), followed by a prospective analysis (1992-1994).
Setting: Hospital HIV inpatient unit. Patients and methods: All patien
ts with Campylobacter spp. identified by the laboratory of microbiolog
y at Saint-Louis Hospital, Paris were studied, and their clinical feat
ures as well as their response to therapy recorded. Results: During th
e study period, Campylobacter infection was documented in 38 HIV-infec
ted patients, 76% of whom had AIDS. Campylobacter spp. was isolated fr
om stools in 36 cases and from blood cultures in four cases. Species i
dentification yielded C. jejuni (84%) and C. coli (16%). High-level re
sistance to quinolones was frequently observed (21%), but resistance t
o erythromycin (3%) and tetracycline (5%) was rare. Diarrhoea, fever a
nd abdominal pain were the main clinical features of infection. Other
intestinal pathogens were found in 42% of patients. Most patients had
an acute illness with rapid resolution under appropriate antimicrobial
therapy. However, eight patients (21%), experienced chronic diarrhoea
with persistent isolation of Campylobacter and in vivo selection of r
esistant strains, requiring multiple courses of antibiotics. Conclusio
ns: Campylobacter usually cause acute diarrhoea in patients with HIV i
nfection. Antimicrobial therapy should be guided on in vitro susceptib
ility testing because of the prevalence of antibiotic resistance. Desp
ite appropriate therapy, some patients will present with prolonged dia
rrhoea and in vivo selection of multiresistant isolates.